Form D · Biotechnology
Altis Biosystems, Inc.
Durham, NC · CIK 0001799892
Offering snapshot reported Apr 7, 2025 · SEC filing
- Reported sold
- $2.13M Offering amount: $2.25M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 31, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 7, 2025 | Initial | $2,126,307 | No comparison | 9 | SEC filing |
| Aug 2, 2022 | Initial | $1,363,658 | No comparison | 17 | SEC filing |
| Jul 22, 2020 | Amendment | $3,103,069 | $2,164,477vs Jan 17, 2020 | 42 | SEC filing |
| Jan 17, 2020 | Initial | $938,592 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-543110
Source: Form D, filed Apr 7, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Biron | Director, Executive |
| Kevin Causey | Director |
| Michael Dial | Director |
| Samuel Franklin | Director |
| Susan Mahony | Director |
| Joseph Mc Mahon | Director |
| Christopher Perkins | Director |
| Benjamin Scruggs | Director, Executive |
| Christopher Sims | Executive |
| Jimmy Smedley | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6 Davis Drive Suite 159
Durham, NC, 27709
Durham, NC, 27709